Guy Pratt

10.1k total citations
184 papers, 5.3k citations indexed

About

Guy Pratt is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Guy Pratt has authored 184 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Hematology, 80 papers in Genetics and 75 papers in Molecular Biology. Recurrent topics in Guy Pratt's work include Multiple Myeloma Research and Treatments (76 papers), Chronic Lymphocytic Leukemia Research (69 papers) and Lymphoma Diagnosis and Treatment (30 papers). Guy Pratt is often cited by papers focused on Multiple Myeloma Research and Treatments (76 papers), Chronic Lymphocytic Leukemia Research (69 papers) and Lymphoma Diagnosis and Treatment (30 papers). Guy Pratt collaborates with scholars based in United Kingdom, United States and Spain. Guy Pratt's co-authors include Paul Moss, Chris Fegan, Chris Pepper, Oliver Goodyear, Gareth J. Morgan, Tatjana Stanković, Jane Starczynski, Mark T. Drayson, Roger G. Owen and Thet Thet Lin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Guy Pratt

171 papers receiving 5.3k citations

Peers

Countries citing papers authored by Guy Pratt

Since Specialization

Citations

This map shows the geographic impact of Guy Pratt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Pratt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Pratt more than expected).

Fields of papers citing papers by Guy Pratt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy Pratt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Pratt. The network helps show where Guy Pratt may publish in the future.

Co-authorship network of co-authors of Guy Pratt

This figure shows the co-authorship network connecting the top 25 collaborators of Guy Pratt. A scholar is included among the top collaborators of Guy Pratt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy Pratt. Guy Pratt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Diagnosis and management of monoclonal gammopathy of renal significance: A British Society for Haematology good practice paper 2025 ·British Journal of Haematology ·Jennifer H. Pinney, Candice Roufosse, (unknown), Aristeidis Chaidos, Julian D. Gillmore, (unknown), (unknown), Karthik Ramasamy, Sarah Blakey, John Ashcroft, (unknown), Paul Cockwell, Guy Pratt	0
2	Laboratory practice is central to earlier myeloma diagnosis: Utilizing a primary care diagnostic tool and laboratory guidelines integrated into haematology services 2024 ·British Journal of Haematology ·Mark T. Drayson, (unknown), (unknown), Dina Patel, Guy Pratt, Suzanne Renwick, Alex Richter, Rachel D. Wheeler, Julie Sheldon, Ross Sadler, (unknown), Fenella Willis, (unknown)	1
3	PembroWM : A phase II trial to investigate the safety and efficacy of rituximab and pembrolizumab in relapsed/refractory Waldenström's Macroglobulinaemia 2024 ·British Journal of Haematology ·Jaimal Kothari, Toby A. Eyre, Ali Rismani, (unknown), (unknown), (unknown), William Wilson, (unknown), Laura Clifton‐Hadley, Helen O. McCarthy, Angela Collins, David Lewis, (unknown), Rebecca Auer, Guy Pratt, Ruth de Tute, Roger G. Owen, Shirley D’Sa	3
4	Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper 2024 ·British Journal of Haematology ·(unknown), Kwee Yong, Karthik Ramasamy, Simon Stern, Eileen M. Boyle, John Ashcroft, Faisal Basheer, Neil Rabin, Guy Pratt	1
5	Extended Intensified Consolidation and Maintenance Improve Ultra High-Risk Multiple Myeloma Patient Outcome - Long-Term Follow-up of the Ukmra Optimum/Muknine Trial 2024 ·Blood ·Martin Kaiser, Andrew Hall, (unknown), Amy Holroyd, Eugene B. Ferris, (unknown), (unknown), Kristian M. Bowles, Mamta Garg, Anand Lokare, Ruth M. de Tute, Mark T. Drayson, Christina Messiou, Roger G. Owen, Richard S. Houlston, Graham Jackson, Gordon Cook, Guy Pratt, Sarah Brown, Matthew Jenner	0
6	National myeloma patient survey shows continuing inappropriate imaging and geographical inequalities 2024 ·British Journal of Radiology ·(unknown), Vicky Goh, (unknown), Guy Pratt	2
7	Presenting Symptoms in Newly Diagnosed Myeloma, Relation to Organ Damage, and Implications for Symptom-Directed Screening: A Secondary Analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) Trial 2023 ·Cancers ·Stella Bowcock, Catherine Atkin, Gulnaz Iqbal, Guy Pratt, Kwee Yong, Richard D Neal, Tim Planche, Kamaraj Karunanithi, (unknown), Simon Stern, (unknown), (unknown), (unknown), Janet Dunn, Mark T. Drayson	0
8	How I Treat Light Chain Cast Nephropathy 2023 ·Clinical Journal of the American Society of Nephrology ·Guy Pratt, Jennifer H. Pinney, Paul Cockwell	0
9	Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma 2023 ·Journal of Clinical Oncology ·Martin Kaiser, Andrew Hall, Katrina Walker, Amy L. Sherborne, Ruth M. de Tute, (unknown), (unknown), Emma Ingleson, Kristian M. Bowles, Mamta Garg, Anand Lokare, Christina Messiou, Richard S. Houlston, Graham Jackson, Gordon Cook, Guy Pratt, Roger G. Owen, Mark T. Drayson, Sarah Brown, Matthew Jenner	54
10	Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic 2023 ·Blood Cancer Journal ·(unknown), (unknown), Graham McIlroy, (unknown), (unknown), Sylvia Feyler, Rakesh Popat, Guy Pratt, Christopher Parrish, A. John Ashcroft, Graham Jackson, Gordon Cook	8
11	Immune responses to COVID‐19 booster vaccinations in intensively anti‐CD38 antibody treated patients with ultra‐high‐risk multiple myeloma: results from the Myeloma UK (MUK) nine OPTIMUM trial 2023 ·British Journal of Haematology ·Sian Faustini, Andrew Hall, Sarah Brown, (unknown), (unknown), Zania Stamataki, Matthew Jenner, Roger G. Owen, Guy Pratt, Gordon Cook, Alex Richter, Mark T. Drayson, Martin Kaiser, Jennifer Heaney	3
12	Renal Disorders Associated with Waldenström Macroglobulinaemia, IgM MGUS and IgM-Producing B-Cell Lymphoproliferative Disorders 2023 ·SHILAP Revista de lepidopterología ·Guy Pratt, (unknown), Jennifer H. Pinney	1
13	Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia 2021 ·Blood Cancer Journal ·Helen Parry, Graham McIlroy, Rachel Bruton, Mohammad Ali, Christine Stephens, Sarah Damery, Ashley Otter, Tina McSkeane, (unknown), Sian Faustini, Najme Wall, Peter Hillmen, Guy Pratt, Shankara Paneesha, Jianmin Zuo, Alex Richter, Paul Moss	74
14	PD-1 is imprinted on cytomegalovirus-specific CD4+ T cells and attenuates Th1 cytokine production whilst maintaining cytotoxicity 2021 ·PLoS Pathogens ·Helen Parry, Alexander C. Dowell, Jianmin Zuo, Kriti Verma, Francesca Kinsella, Jusnara Begum, Wayne Croft, Archana Sharma‐Oates, Guy Pratt, Paul Moss	18
15	MUK nine OPTIMUM protocol: a screening study to identify high-risk patients with multiple myeloma suitable for novel treatment approaches combined with a phase II study evaluating optimised combination of biological therapy in newly diagnosed high-risk multiple myeloma and plasma cell leukaemia 2021 ·BMJ Open ·Sarah Brown, (unknown), Samantha Hinsley, Louise Flanagan, (unknown), Katrina Walker, Andrew Hall, Guy Pratt, Christina Messiou, Matthew Jenner, Martin Kaiser	17
16	Stratifying risk of infection and response to therapy in patients with myeloma: a prognostic study 2020 ·SHILAP Revista de lepidopterología ·(unknown), Jennifer Heaney, Gulnaz Iqbal, Janet Dunn, Stella Bowcock, Tim Planche, Guy Pratt, Kwee Yong, Eric Low, Jill Wood, Kerry Raynes, Helen Higgins, Mark T. Drayson	2
17	Diagnostic pathways in multiple myeloma and their relationship to end organ damage: an analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trial 2020 ·British Journal of Haematology ·Catherine Atkin, Gulnaz Iqbal, Tim Planche, Guy Pratt, Kwee Yong, Jill Wood, Kerry Raynes, Eric Low, Helen Higgins, Richard D Neal, Janet Dunn, Mark T. Drayson, Stella Bowcock, (unknown), (unknown)	5
18	Improving Outcomes for Patients with High-Risk Myeloma Via Prospective Trial Evidence: The Myeloma UK Nine Optimum Trial 2017 ·Blood ·Amy L. Sherborne, Vallari Shah, Sidra Ellis, Farzana Begum, (unknown), David C. Johnson, Roger G. Owen, Mark T. Drayson, Louise Flanagan, (unknown), Walter M. Gregory, Graham Jackson, Guy Pratt, Gordon Cook, Samantha Hinsley, Julia Brown, Matthew Jenner, Martin Kaiser	2
19	Multiple Myeloma with Monoclonal Free IgG3 Heavy Chains and Free Kappa Light Chains 2010 ·Acta Haematologica ·Alex Richter, Stephen Harding, Aarnoud Huissoon, Mark T. Drayson, Guy Pratt	4
20	The telephone: an overlooked technology for prevention in family medicine. 1977 ·PubMed ·(unknown), Guy Pratt	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact